[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].

Subjects

Subjects :

Adult
Anti-Bacterial Agents therapeutic use
Antibodies, Monoclonal administration & dosage
Azathioprine therapeutic use
Crohn Disease complications
Crohn Disease diagnosis
Drug Resistance
Drug Substitution
Duodenal Ulcer etiology
Female
Gastritis complications
Gastritis drug therapy
Gastroscopy
Helicobacter Infections complications
Helicobacter Infections drug therapy
Helicobacter pylori isolation & purification
Humans
Immunosuppressive Agents administration & dosage
Infliximab
Lymphoma, B-Cell, Marginal Zone complications
Mesalamine therapeutic use
Methylprednisolone therapeutic use
Rectovaginal Fistula etiology
Rectovaginal Fistula surgery
Recurrence
Remission Induction
Stomach Neoplasms complications
Antibodies, Monoclonal therapeutic use
Crohn Disease drug therapy
Immunosuppressive Agents therapeutic use

Details

Language :

Spanish; Castilian

ISSN :

0210-5705

Volume :

37

Issue :

1

Database :

MEDLINE

Journal :

Gastroenterologia y hepatologia

Publication Type :

Report

Accession number :

24029174

Full Text :

https://doi.org/10.1016/j.gastrohep.2013.06.008